Navigation Links
Salk to accelerate brain research with $4.5 million NIH grant
Date:10/13/2011

The National Institutes of Health has announced that the Salk Institute will receive $4.5 million to establish a Neuroscience Core Center, a new research center intended to accelerate brain research that lays the foundation for developing new ways to treat congenital brain defects and neurological diseases.

The new center is one of three established nationally this year by the National Institute of Neurological Disorders and Stroke to focus on basic brain research. More than half of Salk's faculty is engaged in neuroscience research, and the five-year grant will support their work by providing access to new technology and expertise.

"We are very excited about this center because it will provide unique services of great use to many of the institute's investigators, and will help expand our understanding of a range of neurological disorders, " says Dennis O'Leary, the Vincent J. Coates Professor of Molecular Neurobiology at Salk, who will serve as director of the new center. "Salk is already a leader in brain research and this center will be an exponential boost to our ability to do cutting-edge research in neuroscience."

The new NIH-funded center will provide research support in three areas that are particularly important for neuroscience: genome manipulation, imaging and behavioral studies.

The genome manipulation core will help scientists develop genetically modified mice as model organisms to study human neurological diseases, such as autism, schizophrenia and Alzheimer's. "We can manipulate embryonic stem cells to make different types of mice that have genes altered to relate to specific diseases," O'Leary says.

The imaging core will focus on electron microscopy and integrating structural analysis across imaging technologies to help scientists visualize the cellular and molecular mechanisms at work in mental disease.

"Brain researchers are increasingly focused on the links between genes and behavior, exploring how genetics play a role in brain development, which is ultimately manifested in a person's ability to function," O'Leary says. "These research cores will provide scientists with greatly needed resources and facilities for accomplishing the goals of this research. By centralizing and expanding these services, the center will provide Salk scientists access to new research technologies and free them from having to reinvent the wheel for each new project."

"This grant from the National Institutes of Health will provide a tremendous boost to the neuroscience research at the Salk, and we are grateful for their continuing support," says Salk Institute President William R. Brody. "Under Dennis O'Leary's leadership this new center will speed discovery of how genetic changes alter abilities such as motor function, learning and memory."


'/>"/>

Contact: Andy Hoang
ahoang@salk.edu
619-861-5811
Salk Institute
Source:Eurekalert  

Related medicine news :

1. UCI-led study links prenatal exposure to stress with accelerated cell aging
2. Cancer cells accelerate aging and inflammation in the body to drive tumor growth
3. Increased metabolic rate may lead to accelerated aging
4. Chronic stress of cancer causes accelerated telomere shortening
5. Porphyromonas gingivalis accelerates inflammatory atherosclerosis in a mouse model
6. Consensus on TBI and PTSD will accelerate future research and improve patient care
7. $4.37 million NCI grant accelerates recent laboratory finding in Ewings sarcoma
8. Stress accelerates breast cancer progression in mice
9. OHSU joins forces with UO, Harvard to accelerate Fanconi anemia research
10. TransforMED Launches New Service Offering to Accelerate Medical Home Adoption in Small Practices
11. Experts call for accelerated national sodium reduction initiatives
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Salk to accelerate brain research with $4.5 million NIH grant
(Date:4/26/2017)... Plano, TX (PRWEB) , ... April 26, 2017 ... ... to confer the distinction of Customer Excellence upon National Registry of Emergency ... , “Customer Engagement drives Financial Performance,” said Dr. Jan G. West, Ph.D. ...
(Date:4/26/2017)... ... , ... RawTrition now brings you BioEnergy which is a powder capsule whole ... , RawTrition is taking nutrients to the next level! The superfoods in RawTrition's ... form (unlike the synthetically made options that are on the market). , Founder of ...
(Date:4/26/2017)... ... April 26, 2017 , ... Bioclinica® ... sponsors and CROs to speed clinical development, has released the industry’s only ... Bioclinica AGILE RTSM provides seamless clinical supply forecasting and management together ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... collaboration, announces Mirroring360 Pro . This new addition to the Mirroring360 product ... for education and business. , Mirroring360 Pro enables educators, business professionals and individuals ...
(Date:4/25/2017)... Amherst, NY (PRWEB) , ... April 25, 2017 , ... ... much stress at work can also decrease overall productivity and performance in the workplace. ... their employees. , During the last few weeks of April, Clearview Resolution Services will ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), a ... Urology, Uro/Gyn and Gynecology markets with innovative and ... joined the Company as Senior Vice President, Marketing ... Mr. Keswani will report directly to Darin ... organization is delighted that Ash has joined the ...
(Date:4/20/2017)... 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a ... significant unmet medical needs, today announced that it ... product development program, based on its proprietary self-delivering ... Dermatology (SID) 76 th Annual Meeting.  The ... sciences relevant to skin health and disease through ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology: